NCT07360860尚未招募不适用
Comparison Between Efficacy and Safety of PRP With Microneedling and Microneedling Alone in Treatment of Macular Amyloidosis; a Split Face Blinded Non Randomized Control Trial With Dermoscopic and Histopathologic Evaluation
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
This study is going to asses and compare the efficacy of treatment of macular amyloidosis using microneedling vs PRP with microneedling. Pruritus and pigmentation will be assessed.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Both genders were included.
- •Patients above 18 years old.
- •Patients diagnosed by macular amyloidosis, proved by dermoscopy and histopathology.
排除标准
- •Prior use of topical therapies in the previous 4 weeks.
- •Prior use of any procedures such as chemical peel or laser treatment in the previous 1 month.
- •Prior use of any systemic treatment for macular amyloidosis in the past 12 weeks.
- •Patients with other skin conditions (e.g., psoriasis, eczema).
- •Immunocompromised patients (HIV, chemotherapy).
- •Patients with history of any type of autoimmune disorders, coagulopathies, and keloid tendency.
- •Known or suspected allergy to ingredients
研究者
Amira Elbendary
Lecturer in Cairo University
Cairo University
相似试验
招募中
不适用
Restoration of Central Vision With PRIMA in Patients With Photoreceptor DegenerationNCT07266584Science Corporation5
招募中
2 期
Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of MyopiaNCT07298824Second Affiliated Hospital of Nanchang University164
尚未招募
3 期
Mirabegron in Patients With Age-Related Macular DegenerationOveractive BladderNCT07305298University of Naples312
招募中
3 期
Atropine in the Treatment of Myopia Study in MalaysiaNCT07329777IDB VisionCare SDN BHD144
招募中
2 期
Phase I/II Follow-up Study of SAR422459 in Patients with Stargardt’s Macular Degeneration2024-513501-31-00Sanofi-Aventis Recherche & Developpement14